Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan After AF Radiofrequency Ablation
ChiCTR2300069585Phase 4Not yet recruiting
- Sponsor
- Shanxi Provincial Hospital of Cardiovascular Diseases
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of azilsartan in Atrial fibrillation (AFib) and hypertension (HTN) (3 arms), sponsored by Shanxi Provincial Hospital of Cardiovascular Diseases. Primary endpoints: Color Doppler ultrasound of the heart, Left atrial size and 3 more. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
azilsartan
03
Conditions
Atrial fibrillation (AFib)hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2300069585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069585.